The depot-specific UCP1 induction in iSAT correlated with reduced adipocyte size (Figure 2), supporting a role for enhanced thermogenesis in the combinatorial therapy’s anti-obesity effects. Here, UCP1 is linked to obesity due to melanocortin 4 receptor deficiency.